Barclays
VCYT icon

Barclays’s Veracyte VCYT Stock Holding History

Barclays’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$936K Sell
29,052
-182,603
-86% -$6.76M ﹤0.01% 2798
2025
Q4 		$8.91M Sell
211,655
-30,697
-13% -$1.24M ﹤0.01% 1765
2025
Q3 		$8.32M Sell
242,352
-57,362
-19% -$1.65M ﹤0.01% 1809
2025
Q2 		$8.1M Buy
299,714
+161,342
+117% +$4.67M ﹤0.01% 1716
2025
Q1 		$4.1M Sell
138,372
-16,966
-11% -$647K ﹤0.01% 2067
2024
Q4 		$6.15M Buy
155,338
+8,936
+6% +$338K ﹤0.01% 1965
2024
Q3 		$4.98M Buy
146,402
+85,033
+139% +$2.39M ﹤0.01% 2100
2024
Q2 		$1.33M Sell
61,369
-27,709
-31% -$583K ﹤0.01% 2416
2024
Q1 		$1.97M Sell
89,078
-87,312
-49% -$2.13M ﹤0.01% 2579
2023
Q4 		$4.85M Buy
176,390
+43,379
+33% +$1.05M ﹤0.01% 2118
2023
Q3 		$2.97M Sell
133,011
-44,209
-25% -$1.14M ﹤0.01% 1659
2023
Q2 		$4.51M Buy
177,220
+31,517
+22% +$764K ﹤0.01% 1411
2023
Q1 		$3.25M Sell
145,703
-29,896
-17% -$723K ﹤0.01% 1838
2022
Q4 		$4.17M Sell
175,599
-51,041
-23% -$1.19M ﹤0.01% 1755
2022
Q3 		$3.76M Buy
226,640
+198,779
+713% +$4.47M ﹤0.01% 1336
2022
Q2 		$555K Sell
27,861
-5,630
-17% -$114K ﹤0.01% 2788
2022
Q1 		$924K Sell
33,491
-60,625
-64% -$1.73M ﹤0.01% 2478
2021
Q4 		$3.88M Sell
94,116
-69,435
-42% -$3.07M ﹤0.01% 1893
2021
Q3 		$7.6M Buy
163,551
+140,186
+600% +$6.12M ﹤0.01% 1348
2021
Q2 		$934K Sell
23,365
-41,447
-64% -$1.77M ﹤0.01% 2700
2021
Q1 		$3.48M Sell
64,812
-38,678
-37% -$2.23M ﹤0.01% 1824
2020
Q4 		$5.07M Sell
103,490
-11,648
-10% -$540K ﹤0.01% 1517
2020
Q3 		$3.74M Buy
115,138
+53,953
+88% +$1.71M ﹤0.01% 1602
2020
Q2 		$1.58M Buy
61,185
+11,816
+24% +$294K ﹤0.01% 2341
2020
Q1 		$1.2M Sell
49,369
-813
-2% -$20.5K ﹤0.01% 2770
2019
Q4 		$1.4M Buy
50,182
+16,650
+50% +$431K ﹤0.01% 3353
2019
Q3 		$805K Sell
33,532
-15,852
-32% -$422K ﹤0.01% 3856
2019
Q2 		$1.41M Buy
49,384
+28,688
+139% +$717K ﹤0.01% 3316
2019
Q1 		$518K Buy
20,696
+7,834
+61% +$150K ﹤0.01% 4081
2018
Q4 		$162K Sell
12,862
-12,978
-50% -$153K ﹤0.01% 4723
2018
Q3 		$247K Buy
25,840
+23,162
+865% +$255K ﹤0.01% 4843
2018
Q2 		$24K Sell
2,678
-2,678
-50% -$18.8K ﹤0.01% 6080
2018
Q1 		$29K Buy
5,356
+1,598
+43% +$9.89K ﹤0.01% 6272
2017
Q4 		$25K Buy
3,758
+3,045
+427% +$22.6K ﹤0.01% 6185
2017
Q3 		$6K Buy
713
+695
+3,861% +$5.65K ﹤0.01% 6367
2017
Q2 		$0 Sell
18
-1,058
-98% -$8.63K ﹤0.01% 6963
2017
Q1 		$10K Buy
+1,076
New +$8.8K ﹤0.01% 6087
2016
Q4 		– Sell
-119
Closed -$1K – 6849
2016
Q3 		$1K Buy
+119
New +$673 ﹤0.01% 6454
2015
Q4 		– Sell
-71
Closed – – 6615
2015
Q3 		$0 Sell
71
-186
-72% -$1.77K ﹤0.01% 7068
2015
Q2 		$3K Buy
257
+58
+29% +$571 ﹤0.01% 6706
2015
Q1 		$2K Sell
199
-171
-46% -$1.4K ﹤0.01% 6887
2014
Q4 		$3K Sell
370
-650
-64% -$5.07K ﹤0.01% 7075
2014
Q3 		$9K Buy
1,020
+907
+803% +$11.9K ﹤0.01% 6953
2014
Q2 		$2K Sell
113
-83
-42% -$1.2K ﹤0.01% 7420
2014
Q1 		$3K Buy
196
+116
+145% +$1.85K ﹤0.01% 7341
2013
Q4 		$1K Buy
+80
New +$1.04K ﹤0.01% 7456

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Barclays's VCYT Position: Q1 2026 in Review

Barclays reduced its Veracyte (VCYT) stake by 86% in Q1 2026, selling an estimated $6.76M and leaving 29,052 shares worth $936K. The position accounts for ﹤0.01% of the portfolio, ranked #2798.

Barclays first reported a position in VCYT in Q4 2013 and has held it in 46 quarters since. The position peaked at $8.91M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Barclays held 29,052 shares of Veracyte worth $936K as of Q1 2026.
  • Barclays sold 182,603 Veracyte shares in Q1 2026, an estimated $6.76M.
  • Veracyte made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2798 holding.
  • Barclays first reported a position in Veracyte in Q4 2013 and has held it in 46 quarters since.
  • Barclays's Veracyte position peaked at $8.91M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.